• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Adv . Copy-back RNA synthesis by coronavirus polymerase requires helicase activity and is stimulated by remdesivir and molnupiravir

tetano

Editor, Senior Moderator
Sci Adv


. 2026 Jun 19;12(25):eadz9231.
doi: 10.1126/sciadv.adz9231. Epub 2026 Jun 19.
Copy-back RNA synthesis by coronavirus polymerase requires helicase activity and is stimulated by remdesivir and molnupiravir

Asif Rakib[SUP] 1 [/SUP], Arnab Das[SUP] 1 [/SUP], Subhas C Bera[SUP] 2 [/SUP], Jelmer Cnossen[SUP] 1 [/SUP], Refugio Robles-Sikisaka[SUP] 3 [/SUP], Meghan V Diefenbacher[SUP] 4 [/SUP], Pim P B America[SUP] 1 [/SUP], Misha Klein[SUP] 1 [/SUP], Thomas K Anderson[SUP] 5 [/SUP], John C Marecki[SUP] 6 [/SUP], Bing Wang[SUP] 7 [/SUP], Eline Bogers[SUP] 1 [/SUP], Joy Y Feng[SUP] 8 9 [/SUP], John P Bilello[SUP] 9 [/SUP], Flávia S Papini[SUP] 2 [/SUP], Quinte Smitskamp[SUP] 1 [/SUP], Timothy P Sheahan[SUP] 4 10 [/SUP], Jamie J Arnold[SUP] 10 [/SUP], Andrew Routh[SUP] 3 [/SUP], Irina Artsimovitch[SUP] 7 [/SUP], Robert N Kirchdoerfer[SUP] 5 [/SUP], Craig E Cameron[SUP] 10 [/SUP], Kevin D Raney[SUP] 6 [/SUP], David Dulin[SUP] 1 2 [/SUP]


Affiliations
Abstract

Polymerase template switching is an essential mechanism in coronaviruses (CoVs) enabling both subgenomic RNA synthesis and increasing genomic diversity via recombination. Despite its importance, the CoV polymerase template-switching molecular mechanism remains unclear. Using magnetic tweezers, we show that the CoV nonstructural protein (nsp) 13-helicase drives intramolecular polymerase template switching, followed by copy-back RNA synthesis. This activity requires nsp13-helicase adenosine triphosphatase activity and a duplex RNA downstream of the CoV polymerase. Remdesivir and molnupiravir are antiviral nucleotide analogs reported to stall the viral polymerase and induce mutations in genome, respectively. Unexpectedly, we show that their incorporation in the nascent strand increases copy-back RNA synthesis in vitro and decreases recombination events in infected cells. We propose a mechanism of action where these analogs' incorporation traps replication complex in a recombination intermediate, preventing viral RNA utilization. Our study highlights the importance of investigating nucleotide analog mechanisms in replication complexes beyond the polymerase.


 
Back
Top